Healthcare Disparities: Encouraging Change Through Continuing Professional Development

Figures & data

Table 1. CPD programmes and associated learning objective.

CPD Program	Learning Objective
Addressing Barriers to Improved Outcomes in African American Patients with Multiple Myeloma	Identify strategies for incorporating culturally sensitive approaches to engage, educate, and advocate for African American patients with multiple myeloma
Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients	Foster collaborative discussions between older patients/caregivers and HCPs on guidelines and recent clinical evidence to guide personalised treatment planning for older patients with MDS
The Biggest Risk to Cardiovascular Health: Addressing Social Determinants of Health in Non-valvular Atrial Fibrillation	Examine effect SDOH and disparities on Non-valvular Atrial Fibrillation anticoagulation prescribing and adherence
Tackling Racial Disparities in Care for HIV and Viral Hepatitis	Implement strategies to combat implicit racial biases that affect optimal care of individuals with or at risk of HIV or viral hepatitis
Racial Disparities and COVID-19: Causes, Consequences, and Clinical Strategies	Identify factors driving COVID-19 racial disparities
Strategies for Addressing Treatment Challenges and Health Inequities in Inflammatory Bowel Disease	Implement strategies to reduce health inequities among patients with Inflammatory Bowel Disease
Smarter. Stronger. Together. Education and Resources to Optimize Clinical Outcomes in Gynecologic Cancers	Identify populations of patients who are at increased risk for poor prognosis and proactively provide education and support throughout all stages of diagnostic and treatment regimens

Table 2. Selected healthcare professions breakdown.

Total Respondents	29303
Physicians	13412 (46%)
Advanced Practice Providers (APPs)	8524 (29%)
Other	2855 (10%)
Pharmacists	2682 (9%)
Registered Nurses	1830 (6%)

Table 3. Assessment question change.

Assessment Questions (N = 43)	Pre-Test	Post-Test	Delta	p-value
Knowledge (n = 25)	39%	65%	25%	p<0.05
Competency (n = 18)	37%	64%	27%	p<0.05

Table 4. Percentage of participants willingness to change practice.

Practical Application to Workflow	Percentage of Participants (n = 1101)
Planned change to practice	34.79%
Apply latest guidelines	43.1%
Choice of treatment/management approach	24.3%
Change in pharmaceutical therapy	8.7%
Change in current practice for referral	12.0%
Change in diagnostic testing	6.2%
Change in differential diagnosis	3.4%
Reinforced current practice	59.31%
No change to practice	5.90%
Formulary restrictions	6.4%
Insurance/financial issues	3.3%
Time constraints	14.3%
Lack of multidisciplinary support	3.3%
System Constraints	5.0%
Treatment-related adverse events	4.6%
Patient adherence	2.0%
None	12.3%

Table

CPD Program	Accredited Education Supported By
Addressing Barriers to Improved Outcomes in African American Patients with Multiple Myeloma	AbbVie Inc., Amgen, BMS, Janssen Biotech, Inc.
Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients	Bristol Myers Squibb. Provided by Rush University Medical Center partnership with the MDS Foundation.
The Biggest Risk to Cardiovascular Health: Addressing Social Determinants of Health in Non-valvular Atrial Fibrillation	Bristol Myers Squibb and Pfizer Alliance
Tackling Racial Disparities in Care for HIV and Viral Hepatitis	Bristol Myers Squibb and Pfizer Alliance
Racial Disparities and COVID-19: Causes, Consequences, and Clinical Strategies	AbbVie, Gilead Sciences, Inc. Janssen Therapeutics
Strategies for Addressing Treatment Challenges and Health Inequities in Inflammatory Bowel Disease	Janssen Biotech, Inc.
Smarter. Stronger. Together. Education and Resources to Optimize Clinical Outcomes in Gynecologic Cancers	AstraZeneca, GlaxoSmithKline and Merck Sharp & Dohme Corp. Provided in partnership with Smart Patients.